Pharmacological targeting of ANO1/TMEM16A in cancer: from channel inhibition to protein downregulation

Yohan Seo, Jiyun Lee, Hyorin Song, Yusol Hwang

Open source

DOI
10.1016/j.pharmthera.2026.109136
Published
2026-11
Container
Pharmacology & Therapeutics
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.pharmthera.2026.109136,
  title = {Pharmacological targeting of ANO1/TMEM16A in cancer: from channel inhibition to protein downregulation},
  author = {Yohan Seo and Jiyun Lee and Hyorin Song and Yusol Hwang},
  year = {2026},
  journal = {Pharmacology \& Therapeutics},
  doi = {10.1016/j.pharmthera.2026.109136},
  url = {https://doi.org/10.1016/j.pharmthera.2026.109136}
}

RIS

TY  - JOUR
TI  - Pharmacological targeting of ANO1/TMEM16A in cancer: from channel inhibition to protein downregulation
AU  - Yohan Seo
AU  - Jiyun Lee
AU  - Hyorin Song
AU  - Yusol Hwang
PY  - 2026
JO  - Pharmacology & Therapeutics
DO  - 10.1016/j.pharmthera.2026.109136
UR  - https://doi.org/10.1016/j.pharmthera.2026.109136
ER  - 

APA

Seo, Y., Lee, J., Song, H., & Hwang, Y. (2026). Pharmacological targeting of ANO1/TMEM16A in cancer: from channel inhibition to protein downregulation. Pharmacology & Therapeutics. https://doi.org/10.1016/j.pharmthera.2026.109136

Source records